Crohn'sUCRecruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Observational · No treatment assigned · 1 site · Brain Inflammation Collaborative
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Post-Acute COVID-19 Syndrome, ME/CFS and Rheumatic Arthritis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 2 and older
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions:
- Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS).
- Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder.
Plus 8 more requirement(s). Only the trial team can confirm whether you qualify.
What's involved
- About 10000 participants are expected to take part.
- Start date: 2023-07-05.
- Main results expected around 2030-06-30 (estimate from the record).
- 1 study site listed (1 marked recruiting) in United States.
Main thing being measured
- Phenotypic data collection (From Baseline through up to 10 years, with assessments approximately every 4-12 weeks)
In the researchers’ words
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Post-Acute COVID-19 Syndrome; ME/CFS; Rheumatic Arthritis; Juvenile Rheumatoid Arthritis (JRA); Psoriatic Arthritis (PsA); Ankylosing Spondylitis (AS); Autoimmune Encephalitis; Celiac Disease; Celiac Disease in Children; Chronic Lyme Disease; Post-treatment Lyme Disease Syndrome; Crohn's Disease; Dysautonomia; Anorexia Nervosa; Bulimia Nervosa; ARFID; Avoidant / Restrictive Food Intake Disorder; Ehlers Danlos Syndrome; Endometriosis; Fibromyalgia (FM); Long COVID; Lupus; Migraines; Mast Cell Activation Syndrome; Multiple Sclerosis; Myalgic Encephalomyelitis (ME); Myasthenia Gravis, Generalized; Myasthenia Gravis in Children; Narcolepsy; Obsessive Compulsive Disorder (OCD); PANDAS; Pediatric Acute-onset Neuropsychiatric Syndrome (PANS); POTS - Postural Orthostatic Tachycardia Syndrome; General Anxiety Disorder, Social Anxiety Disorder; PTSD - Post Traumatic Stress Disorder; Psoriasis; Traumatic Brain Injury; Tourette's Syndrome; Inflammatory Bowel Disease (IBD); Autoimmune Diseases; Neurological Diseases or Conditions; Psychiatric Disorder; Sjogren's Syndrome; Ulcerative Colitis and Crohn's Disease |
| Lead sponsor | Brain Inflammation Collaborative |
| Collaborators | Solve ME/CFS Initiative; Care Evolution; Columbia University |
| Enrollment | 10000 (estimated) |
| Start date | 2023-07-05 |
| Primary completion (est.) | 2030-06-30 |
| First posted | 2021-03-19 |
| Last updated | 2026-01-22 |
| Official title | Unhide® Project Also Known as The Unhide® Solve Together Unified Platform |
| ClinicalTrials.gov ID | NCT04806620 |
Interventions
- None listed
Full eligibility criteria (from the record)
Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions: * Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS). * Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder. * Autoimmune diseases such as Lupus, Sjogren's Disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, and related autoimmune conditions. Inflammatory gastrointestinal conditions such as Crohn's Disease, Celiac Disease, and ulcerative colitis. * Behavioral and mood disorders such as anxiety, depression, bipolar disorder, PTSD, eating disorders, OCD, and other related conditions. * "Healthy" people (without brain inflammation), including unaffected individuals, unaffected individuals in the same household, and unaffected individuals who are married to relatives and family members. * Have consistent internet access and a cell phone, tablet, or PC since this is an online or app-based platform that requires entering data and completing surveys. * Currently live in the United States * Be able to participate in English (stay tuned for updates about the Spanish language version) * Be willing to share symptom and health data through the platform
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Brain Inflammation Collaborative | Delafield, Wisconsin | United States | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.